-+ 0.00%
-+ 0.00%
-+ 0.00%

HUMACYTE ANNOUNCES PHASE 3 V012 TRIAL RESULTS FOR ATEV IN WOMEN REQUIRING HEMODIALYSIS ACCESS ACCEPTED FOR A LATE-BREAKING SESSION PRESENTATION AT ASN KIDNEY WEEK 2026

Reuters·10/12/2026 12:00:01

Please log in to view news